Appendix cancer clinical trials are important research studies that provide patients with opportunities to access cutting-edge treatments very soon after those treatments are discovered. In carefully controlled settings, researchers analyze the effectiveness of these promising new treatments as compared to the current standard of care. The goal is to find new treatments that are more effective, or equally effective with fewer side effects, than the currently available options. Clinical trials are essential pathways that lead to advances in appendix cancer treatment, as well as provide a source of hope, for all patients who are diagnosed with this very rare form of cancer.
When participating in appendix cancer clinical trials, patients can benefit from highly innovative therapies, such as:
- New surgical techniques
- New chemotherapy drugs and drug combinations
- New radiation delivery techniques
Because appendix cancer is so rare, it can sometimes be difficult for patients to find clinical trials. As a high-volume cancer center, Moffitt Cancer Center treats many patients with appendiceal cancer, and we have a robust portfolio of clinical trials of promising new treatments for a variety of gastrointestinal cancers. Our extensive research efforts and groundbreaking discoveries are highly acclaimed; as a result, we’ve earned a Comprehensive Cancer Center designation from the National Cancer Institute.
Individuals who are interested in participating in appendix cancer clinical trials at Moffitt can consult with our multispecialty team of experts with or without referrals. We develop highly individualized treatment plans, making patient health and safety our top priorities. Our team continually monitors each patient’s progress, adjusting treatment as appropriate to ensure the best possible outcome and quality of life.
If you are interested in learning more about appendix cancer clinical trials, the experts at Moffitt can discuss your options and recommend opportunities that are suitable for you. Our team is experienced in matching patients with the clinical trials that are most likely to benefit them. Call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.